CJC-1295 No DAC + Ipamorelin 10mg – Research Peptide

CJC-1295 No DAC + Ipamorelin 10mg research peptide is supplied as a high-purity peptide combination intended strictly for laboratory investigation of growth hormone regulatory signaling pathways and peptide-receptor interaction systems. In controlled research environments, this compound pairing is studied for its interaction with growth hormone releasing hormone (GHRH) receptor pathways and growth hormone secretagogue receptor (GHSR) signaling mechanisms.

The 10mg configuration provides a standardized laboratory format suitable for experimental modeling and receptor pathway analysis.

Research Applications

This peptide combination is evaluated in laboratory research for:

• Growth hormone receptor pathway investigation

• Peptide-mediated signaling analysis

• Hormonal regulatory system modeling

• Intracellular signaling cascade research

• Experimental receptor signaling studies

Its dual-peptide structure differentiates it from single-compound metabolic and mitochondrial signaling peptides.

Metabolic research peptides

Product Specifications

• Compound: CJC-1295 No DAC + Ipamorelin

• Strength: 10mg per vial

• Form: Lyophilized powder

• Purity: Research-grade (see COA)• Storage: Refrigerated conditions recommended

• Intended Use: Laboratory Research Use Only

Certificate of Analysis (COA)

Each batch of CJC-1295 No DAC + Ipamorelin 10mg research peptide is verified for purity and identity.

Current Active Batch:  # ERL-2501-B003-T

View the full Certificate of Analysis here:

View Current COA

Research Use Notice

This compound is supplied strictly for laboratory research use only. Not for human or animal consumption.

Related Growth Hormone Research Peptides

Researchers studying this peptide combination may also examine:

• Ipamorelin 10mg – Research Peptide

• Tesamorelin 10mg – Research Peptide

• IGF-1 LR3 1mg – Research Peptide